Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression.
Article in Molecular Cancer Therapeutics (March 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
CPP, Cell-Penetrating Peptides
Monograph (January 2023)